INTRODUCTION

70
Outcome assessment in HPV natural history studies relies on viral DNA detection from 71 cervical samples collected at fixed intervals, usually every 4-6 months. Several recent studies 72 using highly sensitive PCR-based tests to measure HPV DNA have reported that recurrent 73 detection of an HPV type after a period of non-detection is common, ranging from around 8% to DNA status prior to study entry) and interval sampling (unobserved HPV DNA status between 84 study visits or sample collections), it is likely that a substantial fraction of newly detected HPV 85 in observational studies is misclassified as an initial infection, rather than recurrent detection of a 86 persistent infection (5).
87
In this study, we sought to characterize the temporal variability of detectable HPV DNA Author Manuscript Published OnlineFirst on October 15, 2013; DOI: 10.1158 /1055 assumption that the loss and gain of DNA detection reflected acquisition, clearance, and re-93 infection or deposition of viral DNA from a male partner, we investigated whether recurrent 94 detection or its subsequent loss of detection was associated with sexual activity at follow-up. In 95 the absence of molecular markers to assess the validity of each hypothesis tested, these analyses 96 were intended to evaluate the alternative assumptions for the best fit to the observed data.
98
MATERIALS AND METHODS
99
Study population and design
100
We utilized archived vaginal swabs from a prior study of vaginal douching cessation. The 101 study design and characteristics of the study population were previously described elsewhere (6).
102
In brief, the 16-week study began with a 4-week observational period (phase I) followed by a 12- Johns Hopkins University School of Medicine. There was no evidence suggesting any effect of 107 douching on HPV DNA detectability (7), and we did not observe any difference in HPV 108 detection between the two study phases within the same subjects. Therefore, the current analysis also asked to keep daily diaries on menstrual bleeding and sexual activity during the 16 week 116 follow-up. In both phases, participants self-collected mid-vaginal samples twice per week (every 117 3-4 days). Instructions were provided at baseline on how to perform the self-sampling and to 118 transport the swabs back to the study laboratory. DNA was extracted from the vaginal swab as 119 previously described (8), and genotyped using the Roche HPV LA kit according to the 120 manufacturer's instructions. The detection limit of LA is 10-100 viral copies for each of the 
RESULTS
178
Over the study period, 28 out of 33 women completing both phases I and II of the 179 original study were positive for at least one type of HPV DNA (Table 1) -24.2% and the relative bias was -28.6% (Table 2) . Similarly, the prevalence of HR-types was Author Manuscript Published OnlineFirst on October 15, 2013; DOI: 10.1158 /1055 in relative terms (Table 2) . To reduce the median absolute bias in point prevalence of any-type
208
HPV to less than -10%, four or more consecutive swabs would be needed given the cumulative 209 prevalence in the current study and the sampling interval employed (Table 2) . Similar results to 210 reduce biases when requiring non-consecutive sampling are provided online (see Supplementary 211 Table 1 ).
212
To assess the robustness of our results, we excluded genotypes that appeared only once 213 ("sporadic detections") for each woman over the study period and repeated analyses for the bias 214 quantification. Among 136 ever-positive person-types, 29% were positive on single occasion 215 (n=40) whereas 96 person-types (71%) were detected at least twice (see Supplementary Table 2 ).
216
After excluding these "sporadic" detections, the cumulative prevalence of any type HPV or of 217 HR-types remained the same. The only difference observed was a lower cumulative prevalence 218 of women with multiple-type HPV infection than previously estimated ( Table 3 ). The estimated median time to a new detection was 11 days (95%CI: 10, 228 11). Women with 5 or more lifetime sex partners experienced a 3-day shorter interval between 229 any two events than those without (11 vs. 14 days), suggesting that more recurrent events (median: 10 vs. 9 events) were marginally associated with a higher cumulative sexual exposure.
231
Similarly, women reporting casual sex partners in the previous 12 months were more likely to 232 have frequent incident detections than those without (median time to incident detection: 7 vs. 11 233 days). Older age (>40 years) did not seem to affect women's risk of HPV DNA detection (Table   234 3).
235
Meanwhile, 313 losses of type-specific detection were documented among these 27 236 women; the median number of loss-of-detection events was 10 (IQR: 5-14, Table 4 2013; DOI: 10.1158 /1055 during each sampling interval is not feasible in large natural history studies. This analysis was 254 therefore conducted to quantify possible misclassification in infection status to aid in 255 interpretation of long-interval sampled data, and not to suggest new sampling algorithms.
256
An alternative explanation for the variability in repeated HPV testing results is that these explain the observed variability, we found that the temporal changes were no less frequent 262 among abstinent women than those who were sexually active throughout the follow-up period.
263
Yet, like many others, we were unable to make a clear distinction between persistent infections 264 of low viral load fluctuating around the assay detection limit and re-infections of the same type.
265
Even if women were conferred non-ignorable risks of re-infection by their partners' behavior 266 (about which we had no information), women would also have to be susceptible to the same type 267 that they were infected with as recently as less than 2 weeks ago. However, according to animal 
As a result, we considered low-level persistent infections or intermittent reactivation from 276 viral latency as an equally probable cause of the observed variability in HPV detection. This 277 explanation would be consistent with our observation that women who remained abstinent over 278 the study period and were thus not at risk for new acquisition or re-infection had similarly high 279 variations in viral detection (and non-detection). We have also recently found that, using 6- 
306
In summary, we found that HPV DNA detection was extremely variable over very short 307 intervals. We quantified biases in point estimates as compared to cumulative prevalence when 308 assuming the variability reflected changes in detectability rather than in infection status. We human papillomavirus infection in a long-term follow-up study of female university students.
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